Johnson and Johnson Merck Consumer Pharmaceuticals

Bookmark

Add to MyYahoo RSS

Johnson and Johnson Merck Consumer Pharmaceuticals News

News on Johnson and Johnson Merck Consumer Pharmaceuticals continually updated from thousands of sources around the net.

57 min ago | GigaOM

Johnson & Johnson partners with Organovo to consider 3D-printing living tissue

The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

12 hrs ago | The New Zealand Herald

What's best for baby?

Sharon Dowling, research and development manager for leading company Johnson & Johnson , shares her advice.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 23, 2014

Mother Jones

For Lower Back Pain, You Can Skip the Tylenol

About two-thirds of adults have lower back pain at some point in their lives, and most are told to take acetaminophen, sold under brand names like Tylenol, Anacin and Panadol.

Comment?

Related Topix: Tylenol, Tempra, Acetaminophen (generic), Medicine, Health, Pain, Back Pain, Johnson & Johnson, Biotech, Johnson and Johnson, Healthcare Industry

The Campbell Reporter

Puma Biotech soars on positive breast cancer drug results

Puma Biotechnology' stock soared Wednesday after the company reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.

Comment?

Related Topix: Medicine, Cancer, Health, Breast Cancer, Biotech, Science / Technology, Healthcare Law, Law, Johnson & Johnson, Healthcare Industry

The Motley Fool

Why the Market Is Wrong About Intuitive Surgical Stock

Strong shipments of the Xi system are encouraging, as was the better-than-expected procedure growth, but utilization is still challenging and Revenue fell more than 11% this quarter, but was still about 2% better than the sell-side expected.

Comment?

Related Topix: Startups, Intuitive Surgical, Science / Technology, Robots, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Puma's experimental drug neratinib delayed the return of cancer in a large trial of women with early-stage breast cancer .

Comment?

Related Topix: Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson, Healthcare Industry, Business News

Tue Jul 22, 2014

The Motley Fool

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Here are three quotes from the call and some commentary about why they're so important.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, DePuy Orthopaedics, Hospital Administration, St Peters Health Care Services

Business Journal

Johnson & Johnson board approved $5B stock buyback plan

Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Jersey Journal

Johnson & Johnson volunteers support Buck Garden in Far Hills

Johnson & Johnson 'Day of Caring' volunteers descended upon Somerset County Park Commission Leonard J. Buck Garden at 11 Layton Road in Far Hills.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Far Hills, NJ, Startups

The Hartford Courant

Kevin Hunt: Are These Chemicals In Your Deodorant, Shampoo, Soap Or Cosmetics?

Why do so many people care so much about what they put in their body and so little about what they put on it? Europe's regulatory system bans close to 1,400 ingredients in cosmetic products, including carcinogens like parabens and toxic chemicals that can cause reproductive and developmental-health risks.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, U.S. Environmental Protection Agency, Healthcare Law, Law

Mon Jul 21, 2014

DNA India

Strides Arcolab acquires majority stake in Bafna Pharma

Bangalore-based Strides Arcolab, on Monday, said it has entered into an agreement with Chennai-based Bafna Pharmaceuticals to acquire majority stake of its branded generic business for a cash consideration of Rs 48.1 crore.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

Forbes.com

Daily Dividend Report: JNJ, HAL, AGN, APD, SPN, ZION, BRO

Johnson & Johnson has declared a cash dividend for the third quarter of 2014 of $0.70 per share on the company's common stock.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Barron's

Equal-Weight S&P 500 Breaks Trend: A Caution?

Sterne Agee chartist Carter Braxton Worth highlights what he calls the "poor" state of market breadth in a client note this morning.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

TheStreet.com

Johnson & Johnson (JNJ) Declares 70c Quarterly Dividend

The quarterly dividend is in line with the company's previous. The dividend is payable on Sept.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

World Magazine

Dollars and Sense: Is Wall Street showing signs of 'irrational exuberance?'

Wall Street rising. Stocks rose last week. In fact, Monday, Tuesday, and Wednesday continued a winning streak on the Dow that began the week before.

Comment?

Related Topix: Financial Markets, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Johnson Controls

Fine Woodworking

Protect your lungs ..

I decided to try wearing a simple single-use molded surgical mask when working with my router or table saw or when I produce a lot of wood dust while sanding.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Life, Woodworking, Hobbies

Sun Jul 20, 2014

The Jersey Journal

Work in progress: Johnson & Johnson 'outsider' helps revive recall-plagued consumer unit

To fix Johnson & Johnson's disgraced consumer unit, Sandra Peterson took a gamble, jettisoning several well-known brands, including K-Y Jelly, to concentrate on big sellers such as the pain pill Tylenol.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Startups, Micrus, Scios, OrthoClinical Diagnostics, Medical Equipment

Fri Jul 18, 2014

Examiner.com

Johnson & Johnson inspires caring in children with 'Once Upon A Care'

A good value system is essential when raising a child. You want your child to grow up to be kind, caring and compassionate to everyone who enters their life whether a family member or a stranger.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

Thu Jul 17, 2014

The Jersey Journal

North Brunswick's debt rating gets boost from S&P

Standard and Poor's Ratings Services has upgraded North Brunswick's long-term debt rating to AA+, the agency said in a report on Wednesday.

Comment?

Related Topix: North Brunswick, NJ, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Healthcare Industry

•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••